Drugs / Asprin (300mg)
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07617870 Comparator | Jun 2026 → Dec 2027 expected | ischemic stroke | The First Affiliated Hospital of Zhengzhou University | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Asprin (300mg) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07617870 ↗ |
| Route | Oral | “oral aspirin (300 mg)” NCT07617870 ↗ |